Transcriptomic responses to SIRT1-based gene therapy in glaucomatous retinas
Аннотация
Background Elevated intraocular pressure (IOP) is a pathogenic factor inducing retinal ganglion cell (RGC) degeneration in primary open-angle glaucoma. SIRT1, an NAD⁺-dependent deacetylase with anti-inflammatory, antioxidant stress, and antiapoptotic properties, has shown neuroprotective effects in preclinical models of optic neuropathies. This study investigates the transcriptomic signatures of adeno-associated virus (AAV)-mediated SIRT1 gene delivery to RGCs in a mouse model of ocular hypertension. Results IOP was elevated via intracameral injection of magnetic microbeads (MBs) for 2 or 8 weeks, following intravitreal administration of AAV-SIRT1. RNA sequencing revealed that elevated IOP strongly enriched the retina with gene transcripts related to immune and inflammatory responses, while downregulating those involved in metabolic pathways. Pro-apoptotic genes such as TIMP1 , IFITM3 , TNFSF10 , CEBPA , and LGALS3 were significantly upregulated. AAV-SIRT1 treatment targeted to RGCs partially modified the transcriptomic profile, increasing expression of genes involved in immune regulation ( CD74 , XAF1 ); protein catabolism ( USP18 , ISG15 ); cell adhesion ( ICAM1 ); and neuronal processes ( B2M ). Notably, expression of several stress-related and inflammatory genes ( CREBBP , CLU , PDGFRB , TNFAIP2 , LCP1 , BP9 , ICAM1 , IRF8 , CAPG , and YBX2 ) was normalized. However, key apoptotic markers ( LGALS3 , CEBPA ) remained elevated despite treatment. Conclusions AAV-mediated SIRT1 overexpression in RGCs modulates inflammatory and neuroprotective pathways in retinas under ocular hypertensive stress. It normalizes several SIRT1-regulated inflammatory genes suggesting paracrine neuroimmune effects that extend beyond RGCs. However, this approach does not fully suppress pro-apoptotic pathways. These findings provide a robust framework for understanding SIRT1-based targeted therapy and suggest that additional strategies may be required for complete neuroprotection in glaucoma.